Literature DB >> 1718878

Immunopathology of experimental African sleeping sickness: detection of cytokine mRNA in the brains of Trypanosoma brucei brucei-infected mice.

C A Hunter1, J W Gow, P G Kennedy, F W Jennings, M Murray.   

Abstract

The immunopathology of Trypanosoma brucei brucei in the central nervous system was studied by using an experimental model of chronic meningoencephalitis in outbred CD-1 mice. Mice infected with T. b. brucei were treated with a subcurative dose of the trypanocidal compound diaminazine aceturate. These mice relapsed and were again drug treated. The brains were examined histologically and by immunocytochemistry to identify activated astrocytes. The polymerase chain reaction was used to detect cytokine RNA transcripts. The infected and treated animals developed severe chronic meningoencephalitis characterized by large numbers of inflammatory cells and widespread astrocyte proliferation. In uninfected controls, only interleukin 1 and beta-actin RNA transcripts were detected while transcripts for beta-actin, tumor necrosis factor alpha, macrophage inflammatory protein 1 and interleukins 1 and 4 were demonstrated in the brains of infected animals. Gamma interferon and interleukin 6 were also detected in a few of the infected animals, but interleukin 2 was not found in any of these animals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718878      PMCID: PMC259089          DOI: 10.1128/iai.59.12.4636-4640.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients.

Authors:  V W Pentreath; K Rees; O A Owolabi; K A Philip; F Doua
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Nov-Dec       Impact factor: 2.184

2.  Trypanosomiasis and encephalitis: possible aetiology and treatment.

Authors:  F W Jennings; P E McNeil; J M Ndung'u; M Murray
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Jul-Aug       Impact factor: 2.184

Review 3.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

Authors:  J Le; J Vilcek
Journal:  Lab Invest       Date:  1987-03       Impact factor: 5.662

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 5.  The interleukins.

Authors:  S B Mizel
Journal:  FASEB J       Date:  1989-10       Impact factor: 5.191

6.  Trypanosomiasis in a rural hospital in Tanzania. A retrospective study of its management and the results of treatment.

Authors:  H J Veeken; M C Ebeling; W M Dolmans
Journal:  Trop Geogr Med       Date:  1989-04

7.  Immunohistochemical characterization of the mononuclear cells in the brain of the rat with an experimental chronic Trypanosoma brucei gambiense infection.

Authors:  J A Anthoons; E A Van Marck; P L Gigase; W J Stevens
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

8.  Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.

Authors:  A Waage; A Halstensen; R Shalaby; P Brandtzaeg; P Kierulf; T Espevik
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

9.  Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.

Authors:  P P Nawroth; I Bank; D Handley; J Cassimeris; L Chess; D Stern
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

10.  Early major histocompatibility complex (MHC) class I antigen induction in hypothalamic supraoptic and paraventricular nuclei in trypanosome-infected rats.

Authors:  M Schultzberg; T Olsson; E B Samuelsson; J Maehlen; K Kristensson
Journal:  J Neuroimmunol       Date:  1989-09       Impact factor: 3.478

View more
  15 in total

Review 1.  Human African trypanosomiasis of the CNS: current issues and challenges.

Authors:  Peter G E Kennedy
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

2.  Erythrina abyssinica prevents meningoencephalitis in chronic Trypanosoma brucei brucei mouse model.

Authors:  Johnson Nasimolo; Stephen Gitahi Kiama; Peter Karuri Gathumbi; Andrew Ndegwa Makanya; John Maina Kagira
Journal:  Metab Brain Dis       Date:  2014-01-23       Impact factor: 3.584

3.  Immunobiology of African trypanosomes: need of alternative interventions.

Authors:  Toya Nath Baral
Journal:  J Biomed Biotechnol       Date:  2010-02-23

4.  A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei.

Authors:  P G Kennedy; J Rodgers; F W Jennings; M Murray; S E Leeman; J M Burke
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections.

Authors:  S Magez; M Radwanska; A Beschin; K Sekikawa; P De Baetselier
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction.

Authors:  S Magez; B Stijlemans; G Caljon; H-P Eugster; P De Baetselier
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 7.  Neuroimmunology of Common Parasitic Infections in Africa.

Authors:  Richard Idro; Rodney Ogwang; Antonio Barragan; Joseph Valentino Raimondo; Willias Masocha
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

8.  Production of prostaglandins D2 and E2 by mouse fibroblasts and astrocytes in culture caused by Trypanosoma brucei brucei products and endotoxin.

Authors:  R A Alafiatayo; M R Cookson; V W Pentreath
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

9.  Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii.

Authors:  C A Hunter; J S Abrams; M H Beaman; J S Remington
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response.

Authors:  Lorna Maclean; Martin Odiit; Annette Macleod; Liam Morrison; Lindsay Sweeney; Anneli Cooper; Peter G E Kennedy; Jeremy M Sternberg
Journal:  J Infect Dis       Date:  2007-10-25       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.